Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Latest filing published 07 Jan 2026 for Galecto, Inc.. Read the official filing
Filing timeline
BuySaleL. Becker Hewes
Insider track record
Disclosed buys
0
Disclosed sells
9
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
L. Becker Hewes: trading record in brief
This profile gathers the share dealings of L. Becker Hewes across 2 companies, led by Blueprint Medicines Corp and Damora Therapeutics, Inc. We count 20 filings; the first trade dates from 2 June 2021 and the latest from 5 January 2026.
No open-market purchase appears, only 9 sales worth €1.4M. Outside the open market, there are 6 share grants and 5 option exercises.
The latest filing, published on 7 January 2026, reports a share grant in Damora Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to L. Becker Hewes
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
264,629 shares0Common StockSEC:0001193125-26-006723:0
21,353 sharesCommon StockSEC:0001104659-25-069391:0
4,863 shares@ US$88.8012.2% of flowCommon StockSEC:0001415889-25-007407:0
11,000 shares0Common StockSEC:0001415889-25-006611:0
2,424 shares@ US$104.917.0% of flowCommon StockSEC:0001415889-24-015734:0
10,573 shares@ US$66.2419.3% of flowCommon StockSEC:0001415889-24-015315:0
3,097 shares@ US$90.697.7% of flowCommon StockSEC:0001415889-24-007562:0
12,500 shares0Common StockSEC:0001415889-24-007015:0
1,404 shares@ US$52.052.0% of flowCommon StockSEC:0001415889-23-009402:0
1,466 shares@ US$45.721.9% of flowCommon StockSEC:0001415889-23-004563:0
12,500 shares0Common StockSEC:0001415889-23-004265:0
1,220 shares@ US$59.762.6% of flowCommon StockSEC:0001415889-22-006307:0
2,219 shares@ US$60.004.6% of flowCommon StockSEC:0001415889-22-003186:0
1,047 shares@ US$56.192.1% of flowCommon StockSEC:0001415889-22-002734:0
8,750 shares0Common StockSEC:0001415889-22-002439:0
729 shares@ US$66.241.6% of flowCommon StockSEC:0001179110-21-011105:0
729 shares@ US$66.241.6% of flowCommon StockSEC:0001179110-21-010209:0
729 shares@ US$66.241.6% of flowCommon StockSEC:0001179110-21-009515:0
8,750 shares@ US$66.2418.6% of flowCommon StockSEC:0001179110-21-008827:0
1,292 shares@ US$89.033.6% of flowCommon StockSEC:0001179110-21-008826:0
20 of 20 declarations
